Clark Estates Inc. NY Acquires 7,500 Shares of CVS Health Co. (NYSE:CVS)

Clark Estates Inc. NY lifted its stake in shares of CVS Health Co. (NYSE:CVS) by 19.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 45,375 shares of the pharmacy operator’s stock after buying an additional 7,500 shares during the quarter. Clark Estates Inc. NY’s holdings in CVS Health were worth $2,037,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Widmann Financial Services Inc. grew its holdings in CVS Health by 1.8% in the third quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator’s stock worth $724,000 after purchasing an additional 200 shares during the period. Manchester Capital Management LLC boosted its position in shares of CVS Health by 4.8% during the 4th quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator’s stock worth $200,000 after purchasing an additional 204 shares in the last quarter. Rogco LP increased its position in CVS Health by 3.2% in the 4th quarter. Rogco LP now owns 6,752 shares of the pharmacy operator’s stock valued at $303,000 after buying an additional 210 shares in the last quarter. Hazlett Burt & Watson Inc. raised its stake in CVS Health by 9.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 2,575 shares of the pharmacy operator’s stock worth $163,000 after buying an additional 229 shares during the period. Finally, Glass Jacobson Investment Advisors llc boosted its holdings in CVS Health by 26.8% in the third quarter. Glass Jacobson Investment Advisors llc now owns 1,220 shares of the pharmacy operator’s stock worth $77,000 after acquiring an additional 258 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Evercore ISI boosted their price objective on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a research note on Tuesday, December 3rd. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Leerink Partners raised shares of CVS Health from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $55.00 to $75.00 in a research report on Thursday, February 13th. Finally, Royal Bank of Canada dropped their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $69.83.

Insiders Place Their Bets

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.24% of the company’s stock.

CVS Health Stock Down 1.0 %

CVS opened at $64.26 on Wednesday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company’s 50-day moving average price is $55.14 and its two-hundred day moving average price is $56.58. The stock has a market cap of $81.01 billion, a price-to-earnings ratio of 17.56, a PEG ratio of 0.98 and a beta of 0.61. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, equities analysts expect that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.14%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.